
en
0.25
0.5
0.75
1.25
1.5
1.75
2
Adjuvant trastuzumab in HER2-positive breast cancer
Published on Feb 4, 20253056 Views
Related categories
Presentation
Adjuvant Trastuzumab in HER2-Positive Breast Cancer00:00
Kaj je HER2+ rak dojke00:42
Opis klinične raziskave03:12
Rezultati06:27
Zaključki08:28